查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1372866

一次性注射器市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、按应用、最终用户、地区和竞争细分

Disposable Syringes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 178 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022年，全球一次性注射器市场估值达到142亿美元，预计在预测期内将出现显着成长，预计到2028年复合年增长率（CAGR）为6.10%。

一次性注射器由塑胶筒和针头组成，有多种尺寸可供选择。它们用于将液体、液体或化学物质安全地输送到人体。一次性注射器的主要优点是一次性使用，无需维护和消毒。这不仅降低了营运成本，也最大限度地降低了灭菌后感染的风险。此外，一次性注射器配有针头盖，以保持无菌并防止意外接触。

这些注射器的一次性特性有利于高效率的大规模生产，从而提高成本效益。不同类型的一次性注射器根据尺寸、尖端设计和针长度等因素进行分类，确保各种医疗应用的兼容性和适用性。

市场概况
预测期 2024-2028
2022 年市场规模 142亿美元
2028 年市场规模 203.2亿美元
2023-2028 年复合年增长率 6.10%
成长最快的细分市场 医院和诊所
最大的市场 北美洲

主要市场驱动因素

慢性疾病的盛行率不断上升

慢性病病例的激增和针刺伤害的激增极大地促进了安全注射器市场的成长。根据美国疾病管制与预防中心（CDC）的报告，光是美国就有超过 300 万名医护人员因锐器和皮肤黏膜损伤而接触血液和体液，每年导致 600 万例针刺伤。这些针刺伤造成相当大的感染风险，爱滋病毒的传播率低至 0.2% 至 0.5%，C型肝炎病毒的传播率高达 3% 至 10%。就B型肝炎病毒而言，感染风险可高达 40%。这些感染的潜在致命性促使许多国家强制执行使用安全注射器的强制性规定，因为它们已被证明可以有效减少此类感染。因此，在这些关键因素以及加强病人安全和感染控制措施的迫切需求的推动下，对一次性注射器的需求持续成长。

老年人口的增加

成长的另一个重要推动因素是全球老年人口的不断增加。 2 型糖尿病主要影响 45 岁及以上的族群，但其盛行率在年轻族群中逐渐增加。全球人口 78.75 亿人中，65 岁以上人口约占 9.6%。由于年事已高，老年人口也容易出现糖尿病以外的各种健康问题。这些情况需要医疗护理和药液管理，从而推动了一次性注射器市场的成长。一次性注射器的技术进步增强了其吸引力，并成为市场成长的催化剂。除了治疗各种疾病外，由于各种医疗状况的流行，对采集血液样本的需求不断增长，进一步促进了全球一次性注射器市场的扩大。

全球针刺伤病例增加

针刺伤是由针尖造成的经皮刺伤，已成为医疗机构日益关注的问题。这些伤害可能发生在各种活动中，例如使用、处理、拆卸或处置针头和注射器。由于其高发病率和相关的严重后果，医疗保健专业人员越来越多地使用具有安全机制的注射器来降低风险。对安全性的日益重视正在推动市场对一次性注射器的需求。

据代表欧洲医疗技术行业的组织 Eucomed 称，该地区每年约有 100 万起针刺伤事件。这令人震惊的统计数据凸显了对预防措施和更安全的医疗设备的迫切需求。

全球一次性注射器市场也受到注射药物市场持续成长和护理点管理需求不断增长的影响。随着越来越多的药物透过注射给药，对一次性注射器的需求持续成长。一次性注射器製造的技术进步在推动市场发展方面发挥着至关重要的作用。材料、设计和安全功能方面的创新正在增强一次性注射器的性能和可用性，使医疗保健专业人员更加可靠和方便。针刺伤的普遍存在以及对更安全医疗设备的需求推动了全球一次性注射器市场的发展。随着人们对患者和医护人员安全的日益关注，一次性注射器的需求预计在未来几年将稳步增长。

面临中风风险的患者数量不断增加

面临中风风险的患者数量不断增加，引发了一次性注射器需求的大幅增加。这种日益增长的医疗保健问题是多种因素的直接后果，包括人口老化、生活方式的改变以及高血压和糖尿病等慢性疾病的整体上升。随着个体年龄的增长，他们对中风和相关併发症的易感性增加，需要频繁的医疗干预和注射。

一次性注射器已成为预防、诊断和治疗中风相关问题不可或缺的工具。患有中风或有中风风险的患者通常需要定期进行血液检查，以监测他们的胆固醇水平、凝血因子和血糖水平。这些注射器在精确抽取血液样本、最大限度地降低污染风险以及确保医疗保健专业人员和患者的安全方面发挥关键作用。

透过一次性注射器施用抗凝血剂和溶栓剂等药物在中风患者的治疗中已变得司空见惯。这些注射器的一次性使用性质确保了准确的剂量，降低了感染风险，并消除了复杂的灭菌过程的需要，从而改善了患者的整体护理和安全。中风危险因子的日益普及增加了医疗保健领域对一次性注射器的需求。这些多功能仪器不仅有助于诊断和治疗中风，而且有助于管理相关疾病，使其成为解决日益严重的中风流行病的现代医疗实践的重要组成部分。随着医疗保健提供者努力为不断扩大的患者群体提供最高标准的护理，一次性注射器在中风管理中的作用将变得更加重要。

主要市场挑战

一次性成本较高

在不发达经济体，甚至在发展中经济体的某些地区，人们对医疗保健和安全问题的认识严重缺乏。这种认知的缺乏构成了严重的风险，因为人们仍然没有意识到使用不可伸缩注射器的不安全做法可能导致多种传染病和感染的迅速传播。这种情况的后果可能是致命的，进一步加剧了解决这个问题的迫切性。

此外，在低度开发国家，基础设施不足、资源有限、教育不足和技术不足等诸多挑战导致人们对医疗中心的安全法和最佳实践总体缺乏认识。这些因素，再加上与传统注射器相比，可伸缩安全注射器的成本相对较高，成为市场成长和采用更安全的医疗保健实践的主要限制因素。

应对这些多方面的挑战需要各利益相关者的共同努力，包括政府、医疗保健组织和国际机构。透过优先考虑教育、改善基础设施和促进获得负担得起的安全注射器，我们可以努力为所有人创造一个更安全的医疗环境，无论其地理位置或经济状况如何。

严格的政府法规

严格的政府法规对一次性注射器的需求产生了重大影响，为製造商和医疗保健提供者创造了一个充满挑战的环境。虽然实施法规的目的通常是确保安全和品质标准，但有时它们可能会无意中阻碍一次性注射器的可及性和可负担性。严格法规影响需求的关键因素之一是对製造商实施严格的认证和批准流程。这些过程通常需要大量的时间和财力，导致市场进入延迟和生产成本增加。因此，这些额外的费用通常会转嫁给医疗机构和消费者，从而使一次性注射器更加昂贵并减少其整体需求。

虽然严格的政府法规对于确保一次性注射器等医疗器材的安全性和有效性至关重要，但它们可能会因增加生产成本、限制创新和推高价格而无意中阻碍需求。平衡安全需求与负担得起且易于使用的医疗保健工具的需求是一项微妙的任务，政策制定者必须仔细考虑，确保法规不会阻碍一次性注射器在医疗保健服务中发挥的重要作用。

主要市场趋势

政府和组织越来越多的倡议

各国政府和国际卫生组织越来越重视免疫和疫苗接种运动。这种关注，特别是考虑到新冠肺炎 (COVID-19) 大流行等全球健康危机，导致疫苗生产和分发工作激增。一次性注射器在这方面至关重要，因为它们确保了疫苗的准确和安全管理。随着各国政府致力于大规模疫苗接种活动并加强医疗基础设施，对一次性注射器的需求必将飙升。旨在减少传染病传播的措施正在推动对安全注射实践的需求。各国政府和组织越来越多地投资于减少伤害计划，特别是在面临静脉注射毒品和爱滋病毒传播相关挑战的地区。这些计划通常涉及分发无菌的一次性注射器，以尽量减少感染风险。因此，随着这些减少伤害努力的扩大，对一次性注射器的需求预计将会增加。

此外，人们越来越认识到医疗保健卫生和感染控制的重要性，这进一步刺激了对一次性注射器的需求。世界各地的医院、诊所和医疗机构正在采取更严格的协议，以尽量减少医疗相关感染的风险。一次性注射器本质上是无菌且一次性的，是实现这些目标的关键组成部分。

自动注射器的使用不断增加

由于自动注射器技术的快速进步，加上外科手术中对安全注射器的市场需求不断增加，一次性注射器产业正在经历逐步转型。目前，已有20多家製药公司生产了近80种自动注射器，大约有50种药物正在开发为与自动注射器一起使用的组合产品。其中，一次性自动注射器占62%的市场份额，而各种​​剂量的可重复使用自动注射器正在以惊人的速度开发中。设备製造业强调对使用者友善的小工具的需求，无论是紧急使用还是慢性医疗状况。

值得注意的是，大约有 13 亿支带有胰岛素药筒的一次性笔在流通，为可重复使用的笔提供了大显示器、剂量调节和轻鬆更换药筒等便利。自动注射器作为一种实用的药物输送方式已广受欢迎，特别是对于灵活性有限的患者。大多数自动注射器是一次性的、一次性的、弹簧加载的注射器。患者和照护者越来越多地参与选择一次性自动注射器的最佳治疗方案，这是该市场收入成长的关键驱动力。

细分市场洞察

产品洞察

根据产品，市场分为传统注射器和安全注射器。 2022 年，安全一次性注射器细分市场在市场中占据最高的收入份额。这主要归因于人们对医疗保健环境中安全措施重要性的认识不断提高，以及防止针刺伤的需求不断增长。此外，由于注射不当导致B型肝炎、C型肝炎和爱滋病毒等血液传染疾病的高流行，进一步刺激了对安全注射器的需求。医疗保健专业人员和组织越来越多地采用安全注射器作为预防措施，以降低感染风险并确保病患安全。对感染控制方案的日益重视和医疗机构严格法规的实施也促进了市场的成长。

应用洞察

按应用划分，市场分为免疫注射剂和治疗注射剂。 2022年，免疫注射细分市场在市场中占据了重要的收入份额。免疫注射的重要性在于其在预防疾病传播和保护公众健康方面的作用。由于疫苗接种主要是一项群众活动，因此确保该过程的安全性和有效性变得至关重要。因此，必须尽量减少传播血源性病原体的风险，而实现这一目标的方法之一是避免重复使用注射器和针头，这有助于降低针刺伤的风险。

注射剂的选择也取决于多种因素，包括安全性、成本和所注射疫苗的类型。如果所有疫苗均以预先安装形式提供，通常建议使用预先安装自动失效注射器。这些注射器为注射疫苗提供了便利、准确和安全，进一步增强了整体免疫过程。确保正确的注射方法，例如使用正确类型的注射器和针头，对于维持免疫过程的完整性和确保公众健康起着至关重要的作用。

区域洞察

2022 年，北美地区成为市场领导者，收入比重最高。这可以归因于多种因素，包括该地区大量提供一次性注射器，这促进了对注射药物的需求不断增长。此外，该地区慢性疾病和生活方式疾病的日益普及进一步加剧了这一趋势。此外，人们越来越重视确保患者和医疗保健提供者的安全，预计这将显着推动市场扩张。

此外，北美先进的医疗基础设施，加上高素质的医疗专业人员，导致医院、专科诊所和诊断设施等各种医疗机构中一次性注射器的使用量大幅增加。一次性注射器的广泛采用凸显了该地区为其人民提供安全且高效的医疗保健服务的承诺。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球一次性注射器市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 副产品（传统注射器、安全注射器）
    • 按应用（免疫注射剂、治疗注射剂）
    • 按最终使用者（医院和诊所、门诊护理中心、诊断中心、其他）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美一次性注射器市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲一次性注射器市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区一次性注射器市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲一次性注射器市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲一次性注射器市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非一次性注射器
    • 沙乌地阿拉伯 一次性注射器
    • 阿联酋一次性注射器

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：定价分析

第 14 章：全球一次性注射器市场：SWOT 分析

第 15 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第16章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Gerresheimer AG
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • B. Braun SE
    • Cardinal Health, Inc.
    • Schott AG
    • Hindustan Syringes & Medical Devices Ltd
    • Nipro Corporation
    • Retractable Technologies Inc.
    • Terumo Corporation

第 17 章：策略建议

第 18 章：关于我们与免责声明

简介目录
Product Code: 5165

In 2022, the Global Disposable Syringes Market reached a valuation of USD 14.20 billion, and it is poised for remarkable growth in the forecast period with a projected Compound Annual Growth Rate (CAGR) of 6.10% through 2028.

Disposable syringes consist of a plastic barrel and a needle, available in various sizes. They are employed for the safe administration of fluids, liquids, or chemicals into the human body. The key advantage of disposable syringes is their single-use nature, eliminating the need for maintenance and sterilization. This not only reduces operational costs but also minimizes the risk of post-sterilization infections. Additionally, disposable syringes are equipped with needle covers to maintain sterility and prevent accidental contact.

The disposability of these syringes facilitates efficient mass production, resulting in cost-effectiveness. Different types of disposable syringes are categorized based on factors such as size, tip design, and needle length, ensuring compatibility and suitability for various medical applications.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 14.20 Billion
Market Size 2028USD 20.32 Billion
CAGR 2023-20286.10%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Key Market Drivers

Growing Prevalence of Chronic Disorders

The surge in the cases of chronic disease and surging needle stick injuries are significantly contributing to the growth of the safety syringe market. According to a report by the Centers for Disease Control and Prevention (CDC), more than 3 million healthcare workers in the United States alone are exposed to blood and body fluid through sharp and mucocutaneous injuries, resulting in 6 million needlestick injuries annually. These needlestick injuries pose a considerable risk of infections, with transmission rates ranging from as low as 0.2% to 0.5% for HIV to as high as 3% to 10% for the Hepatitis C virus. In the case of the Hepatitis B virus, the risk of infection can escalate to a staggering 40%. The potential fatality of these infections has prompted many countries to enforce mandatory regulations for the use of safety syringes, as they have proven to be effective in reducing such infections. As a result, the demand for disposable syringes continues to grow, driven by these critical factors and the pressing need for enhanced patient safety and infection control measures.

Increase In the Geriatric Population

Another significant driver for growth is the escalating geriatric population worldwide. Type 2 Diabetes primarily affects individuals aged 45 and above, but its prevalence is gradually increasing among younger age groups. Approximately 9.6% of the global population, which stands at 7.875 billion people, comprises individuals aged 65 and above. The geriatric population is also prone to various health conditions beyond diabetes due to their advanced age. These conditions necessitate medical attention and the administration of medicinal fluids, thereby fueling the growth of the Disposable Syringes market. Technological advancements in Disposable Syringes enhance their appeal and act as catalysts for market growth. In addition to treating various diseases, the rising demand for collecting blood samples, driven by the prevalence of diverse medical conditions, further contributes to the expansion of the Global Disposable Syringes Market.

The increasing instances of botox injections also propel the demand for disposable syringes, consequently driving market growth. According to the plastic surgery statistics report from the American Society of Plastic Surgeons, approximately 7.4 million botulinum toxin (Botox) injections and 2.6 million dermal filler injections were administered in 2018.

Rise in Global Cases of Needle-stick Injuries

Needle-stick injuries, which are percutaneous piercing wounds caused by needle tips, have become a growing concern in healthcare settings. These injuries can occur during various activities such as using, handling, disassembling, or disposing of needles and syringes. Due to their high incidence rate and associated serious consequences, healthcare professionals are increasingly using syringes with safety mechanisms to mitigate the risk. This growing emphasis on safety is driving the demand for disposable syringes in the market.

According to Eucomed, an organization representing the medical technology industry in Europe, approximately 1 million needle-stick injuries occur in the region each year. This alarming statistic highlights the urgent need for preventive measures and safer medical devices.

The global disposable syringes market is also influenced by the sustained growth of the injectable drugs market and the increasing demand for point-of-care administration. As more medications are administered through injections, the demand for disposable syringes continues to rise. Technological advancements in the manufacturing of disposable syringes play a crucial role in driving the market forward. Innovations in materials, design, and safety features are enhancing the performance and usability of disposable syringes, making them more reliable and convenient for healthcare professionals. The prevalence of needle-stick injuries and the need for safer medical devices have propelled the global disposable syringes market. With the increasing focus on patient and healthcare worker safety, the demand for disposable syringes is expected to grow steadily in the coming years.

Increasing Number of Patients At Risk Of Developing Stroke

The increasing number of patients at risk of developing strokes has triggered a significant surge in the demand for disposable syringes. This growing healthcare concern is a direct consequence of several factors, including an aging population, lifestyle changes, and an overall rise in chronic health conditions such as hypertension and diabetes. As individuals age, their susceptibility to strokes and related complications rises, necessitating frequent medical interventions and injections.

Disposable syringes have become an indispensable tool in the prevention, diagnosis, and treatment of stroke-related issues. Patients suffering from strokes or at risk of developing them often require regular blood tests to monitor their cholesterol levels, coagulation factors, and glucose levels. These syringes play a pivotal role in drawing blood samples with precision, minimizing the risk of contamination, and ensuring the safety of healthcare professionals and patients alike.

The administration of medications, such as anticoagulants and thrombolytics, through disposable syringes has become commonplace in the management of stroke patients. The single-use nature of these syringes ensures accurate dosing, reduces the risk of infections, and eliminates the need for complex sterilization processes, thus improving overall patient care and safety. The increasing prevalence of stroke risk factors has intensified the demand for disposable syringes in the healthcare sector. These versatile instruments are not only instrumental in diagnosing and treating strokes but also in managing associated conditions, making them an essential component of modern medical practice in addressing the growing stroke epidemic. As healthcare providers strive to deliver the highest standard of care to an expanding patient base, the role of disposable syringes in stroke management is set to become even more crucial.

Key Market Challenges

Comparatively High One-time Cost

In underdeveloped economies and even in some regions of developing economies, there exists a significant lack of awareness regarding healthcare and safety issues. This lack of awareness poses a grave risk, as people remain oblivious to the fact that the unsafe practice of using non-retractable syringes can lead to the rapid spread of numerous contagious diseases and infections. The consequences of such situations can be fatal, further exacerbating the urgency to address this issue.

Moreover, in underdeveloped countries, a multitude of challenges such as inadequate infrastructure, limited resources, inadequate education, and insufficient technology contribute to the overall lack of awareness about safety laws and best practices in healthcare centers. These factors, combined with the comparatively higher cost of retractable safety syringes compared to conventional syringes, act as major restraints to the market's growth and the adoption of safer healthcare practices.

Addressing these multifaceted challenges requires concerted efforts from various stakeholders, including governments, healthcare organizations, and international bodies. By prioritizing education, improving infrastructure, and facilitating access to affordable safety syringes, we can work towards creating a safer healthcare environment for all individuals, regardless of their geographical location or economic status.

Stringent Government Regulations

Stringent government regulations have had a significant impact on the demand for disposable syringes, creating a challenging environment for both manufacturers and healthcare providers. While regulations are often implemented with the intention of ensuring safety and quality standards, they can sometimes unintentionally hinder the accessibility and affordability of disposable syringes. One of the keyways in which stringent regulations affect demand is through the rigorous certification and approval processes imposed on manufacturers. These processes often demand substantial time and financial resources, leading to delayed market entry and increased production costs. Consequently, these added expenses are often passed on to healthcare facilities and consumers, making disposable syringes more expensive and reducing their overall demand.

While stringent government regulations are essential for ensuring the safety and efficacy of medical devices like disposable syringes, they can inadvertently impede demand by increasing production costs, limiting innovation, and driving up prices. Balancing the need for safety with the need for affordable and accessible healthcare tools is a delicate task that policymakers must carefully consider ensuring that regulations do not hinder the vital role disposable syringes play in healthcare delivery.

Key Market Trends

Increasing Initiatives by Governments and Organizations

Governments and international health organizations are placing a growing emphasis on immunization and vaccination campaigns. This focus, especially in light of global health crises like the COVID-19 pandemic, has led to a surge in vaccine production and distribution efforts. Disposable syringes are pivotal in this context, as they ensure accurate and safe administration of vaccines. As governments commit to mass vaccination campaigns and bolster their healthcare infrastructure, the demand for disposable syringes is set to soar. Initiatives aimed at reducing the transmission of infectious diseases are driving up the demand for safe injection practices. Governments and organizations are increasingly investing in harm reduction programs, particularly in regions facing challenges related to intravenous drug use and HIV transmission. These programs often involve the distribution of sterile, single-use syringes to minimize the risk of infections. Consequently, the demand for disposable syringes is expected to increase as these harm reduction efforts expand.

Moreover, there is a growing recognition of the importance of healthcare hygiene and infection control, which further fuels the demand for disposable syringes. Hospitals, clinics, and healthcare facilities worldwide are adopting stricter protocols to minimize the risk of healthcare-associated infections. Disposable syringes, being inherently sterile and single-use, are a crucial component in achieving these objectives.

Rising Use of Autoinjector Syringes

The disposable syringe industry is undergoing gradual transformation attributed to rapid technological advancements in auto injector syringes, coupled with increasing market demand for safety syringes in surgical procedures. Currently, over 20 pharmaceutical companies have produced nearly 80 autoinjectors, with approximately 50 medications being developed as combination products for use with autoinjectors. Among these, disposable autoinjectors account for 62% of the market share, while reusable autoinjectors with various doses are being developed at an impressive pace. The device manufacturing industry has emphasized the need for user-friendly gadgets, both for emergency use and chronic medical conditions.

Notably, there are approximately 1.3 billion disposable pens with insulin cartridges in circulation, offering conveniences such as a large display, dose adjustment, and easy cartridge replacement for reusable pens. Autoinjector syringes have gained popularity as a practical means of medication delivery, particularly for patients with limited dexterity. Most autoinjectors are one-use, disposable, and spring-loaded syringes. The increasing involvement of patients and caregivers in selecting the optimal treatment option for disposable autoinjector syringes is a key driver for the revenue growth in this market.

Segmental Insights

Product Insights

On the basis of product, the market is fragmented into conventional syringe and safety syringe. The safety disposable syringe segment held the highest revenue share in the market in 2022. This is primarily attributed to the increasing awareness about the importance of safety measures in healthcare settings and the rising need to prevent needlestick injuries. Moreover, the high prevalence of blood-borne transmission diseases like hepatitis B, C, and HIV due to improper injection practices has further fueled the demand for safety syringes. Healthcare professionals and organizations are increasingly adopting safety syringes as a preventive measure to reduce the risk of infections and ensure patient safety. The growing emphasis on infection control protocols and the implementation of stringent regulations in healthcare facilities are also contributing to the market growth.

Application Insights

By application, the market is bifurcated into immunization injections and therapeutic injections. In 2022, the immunization injections segment garnered a significant revenue share in the market. The importance of immunization injections lies in their role in preventing the spread of diseases and protecting public health. As vaccination is primarily a mass activity, it becomes crucial to ensure the safety and efficacy of the process. Therefore, the risk of spreading blood-borne pathogens must be minimized, and one way to achieve this is by avoiding syringe and needle reuse, which helps reduce the risk of needle stick injuries.

The choice of injections used also depends on various factors, including the safety, cost, and type of vaccine to be administered. If all vaccines are available in the prefilled form, prefilled auto-disable syringes are often recommended. These syringes provide convenience, accuracy, and safety in administering vaccines, further enhancing the overall immunization process. Ensuring proper injection practices, such as using the right type of syringe and needle, plays a vital role in maintaining the integrity of the immunization process and safeguarding public health.

Regional Insights

In 2022, the North America region emerged as the leader in the market, generating the highest revenue share. This can be attributed to several factors, including the region's extensive availability of disposable syringes, which has facilitated the growing demand for injectable drugs. Moreover, the increasing prevalence of chronic and lifestyle diseases in the region has further contributed to this trend. Additionally, there is a growing emphasis on ensuring patient and healthcare provider safety, which is expected to significantly drive market expansion.

Furthermore, the advanced healthcare infrastructure in North America, coupled with highly qualified medical professionals, has resulted in a substantial surge in the use of disposable syringes across various healthcare settings such as hospitals, specialist clinics, and diagnostic facilities. This widespread adoption of disposable syringes underscores the region's commitment to providing safe and efficient healthcare services to its population.

Key Market Players

  • Gerresheimer AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • B. Braun SE
  • Cardinal Health, Inc.
  • Schott AG
  • Hindustan Syringes & Medical Devices Ltd
  • Nipro Corporation
  • Retractable Technologies Inc.
  • Terumo Corporation

Report Scope:

In this report, the Global Disposable Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Disposable Syringes Market, By Product:

  • Conventional Syringes
  • Safety Syringes

Disposable Syringes Market, By Application:

  • Immunization Injections
  • Therapeutic Injections

Disposable Syringes Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centres
  • Diagnostic Centres
  • Others

Disposable Syringes Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Disposable Syringes Market.

Available Customizations:

  • Global Disposable Syringes market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Disposable Syringes Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Conventional Syringes, Safety Syringes)
    • 5.2.2. By Application (Immunization Injections, Therapeutic Injections)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centres, Diagnostic Centres, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Disposable Syringes Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Disposable Syringes Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Disposable Syringes Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Disposable Syringes Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Disposable Syringes Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Disposable Syringes Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Disposable Syringes Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Disposable Syringes Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Disposable Syringes Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Disposable Syringes Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Disposable Syringes Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Disposable Syringes Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Disposable Syringes Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Disposable Syringes Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Disposable Syringes Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Disposable Syringes Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Disposable Syringes Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Disposable Syringes Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Disposable Syringes Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Disposable Syringes Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Disposable Syringes Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Disposable Syringes Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Disposable Syringes Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Disposable Syringes Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Pricing Analysis

14. Global Disposable Syringes Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Business Overview
  • 16.2. Service Offerings
  • 16.3. Recent Developments
  • 16.4. Key Personnel
  • 16.5. SWOT Analysis
    • 16.5.1. Gerresheimer AG
    • 16.5.2. Baxter International Inc.
    • 16.5.3. Becton, Dickinson and Company
    • 16.5.4. B. Braun SE
    • 16.5.5. Cardinal Health, Inc.
    • 16.5.6. Schott AG
    • 16.5.7. Hindustan Syringes & Medical Devices Ltd
    • 16.5.8. Nipro Corporation
    • 16.5.9. Retractable Technologies Inc.
    • 16.5.10. Terumo Corporation

17. Strategic Recommendations

18. About Us & Disclaimer